header logo image


Page 25«..1020..24252627..3040..»

Archive for the ‘Biotechnology’ Category

Clinical Decision Support Systems (CDSS) Market Application Products, Applications with Biotechnology and Nature Research Report 2020 – Owned

Monday, July 6th, 2020

Clinical Decision Support Systems (CDSS) Market Trends By Component (Software), Product (Integrated CDSS), Model (Knowledge-Based CDSS) Delivery Mode (On-Premise CDSS), Mode of Advice (Active CDSS), Setting (Inpatient Setting), Type (Therapeutic CDSS), Application (Advanced CDSS), Growth Opportunity, Size, Demand, Technology and Regional Analysis Global Forecast Till 2023.

The Clinical Decision Support Systems (CDSS) Market Size is set to witness a CAGR of 12%, which projects above-average growth for the global market.

The Clinical Decision Support Systems (CDSS) market is growing significantly over the past few years. The healthcare industry is witnessing a spurting growing due to the ever-increasing population that is prompting the need for effective treatment and care. The Players that leads the global CDSS market include

Request for a FREE [emailprotected]https://www.marketresearchfuture.com/sample_request/6038

By Latest Product launches and investment in R&D are a few of the important strategies employed by the top players in the global market to facilitate growth.

Prominent players analyzed in the report include

Allscripts

Carestream

Agfa-Gevaert Group

Elsevier B.V.

Athenahealth

Hearst Health

Cerner Corporation

Meditech

and Epic Systems Corporation

Wolters Kluwer Health

and among others.

Clinical Decision Support Systems (CDSS) Market Segmentation:

The global CDSS market is segmented into component, product, model, delivery mode, mode of advice, settings, type, application, and region. By component, the market is segmented into services, software, and hardware. Software accounted for the largest share of the market and valued USD 493.43 million in 2017 and is expected to maintain its lead while reaching an evaluation of USD 982.42 million by the end of 2023.

By product, the market is segmented into integrated CDSS and standalone CDSS. Integrated CDSS is found to have the majority share and is expected to grow at the fastest CAGR. Integration allows healthcare professionals to access solutions that are interconnected and share a common user interface and database, thus simplifying the process.

By model, the market is segmented into Knowledge-based CDSS, and Non-Knowledge-based CDSS. Knowledge-based CDSS accounts for the majority share of the market due to the high number of advantages this system has over non-knowledge based CDSS.

By delivery mode, the market is segmented into in-premise and cloud-based systems. With global technology moving toward adoption of cloud-based systems, the healthcare sector is no different. The low capital and operational costs incurred in the implementation of cloud-based systems is highly beneficial as compared to on-premise systems.

By mode of advice, the market is segmented into passive CDSS and active CDSS. The active CDSS segment accounts for the largest share of the market with approximately 75% of the total share.

By settings, the market is segmented into inpatient settings and ambulatory care settings. Inpatient settings account for over 70% of the total market due to the requirement of a large volume of patient data that is captured and analyzed by healthcare professionals.

By type, the market is segmented into therapeutic clinical decision support system and diagnostic clinical decision support system. Due to its ability to transform clinical health practices by providing a user interface with the best therapeutic practices, the therapeutic CDSS segment has the leading market position.

By application, the market is segmented into conventional clinical support systems and advanced clinical decision support system. The advanced CDSS segment accounts for the largest segment with the highest CAGR of 12.34% during the assessment period. Users of CDSS has opting to upgrade conventional systems to include premium functions such as treatment planning protocol, population health management, patient record management, protocol validation, reasoning based models and health economics management too.

Browse Complete Premium Report [emailprotected]https://www.marketresearchfuture.com/reports/clinical-decision-support-systems-market-6038

18 LIST OF TABLES

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20152023 (USD MILLION)

TABLE 3 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY REGION, 20152023 (USD MILLION)

TABLE 4 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY REGION, 20152023 (USD MILLION)

TABLE 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY REGION, 20152023 (USD MILLION)

TABLE 6 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20152023 (USD MILLION)

TABLE 7 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INTEGRATED CDSS, BY REGION, 20152023 (USD MILLION)

TABLE 8 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR STANDALONE CDSS, BY REGION, 20152023 (USD MILLION)

TABLE 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20152023 (USD MILLION)

TABLE 10 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR KNOWLEDGE-BASED CDSS, BY REGION, 20152023 (USD MILLION)

TABLE 11 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR NON-KNOWLEDGE-BASED CDSS, BY REGION, 20152023 (USD MILLION)

Continued

Contact:

Market Research Future, Pune 411028

Maharashtra, India

+1 646 845 9312

Email:[emailprotected]

See the original post here:
Clinical Decision Support Systems (CDSS) Market Application Products, Applications with Biotechnology and Nature Research Report 2020 - Owned

Read More...

2020 Impact of COVID-19 on Food Biotechnology Size, Share, Growth, Demand and Forecast to 2026 – Owned

Monday, July 6th, 2020

It is our aim to provide our readers with report for Food Biotechnology Market, which examines the industry during the period 2020 2026. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the Food Biotechnology Market report. Next, the document will study the factors responsible for hindering and enhancing growth in the industry. After covering various areas of interest in the industry, the report aims to provide how the Food Biotechnology Market will grow during the forecast period.

The major vendors covered:

ArcadiaBiosciences, AquaBountyTechnologies, BASFPlantScience, Bayer CropScienceAG, Camson Bio Technologies, DowDuPont, EvogeneLtd, Hy-LineInternational, KWS Group, Monsanto, Origin Agritech, Syngenta AG, etc and more

The final report will add the analysis of the Impact of Covid-19 on Food Biotechnology Market.

Request a free sample copy @ https://www.reportsandmarkets.com/sample-request/global-food-biotechnology-market-size-status-and-forecast-2018-2025?utm_source=primefeed&utm_medium=38

The Food Biotechnology Market report between the years 2020 2026 will highlight the current value of the industry. At the same time, there is also an estimate of how much this line of business will be worth at the end of the forecast period. As it is our goal to maintain high levels of accuracy at all times, we will take a look at the CAGR of the Food Biotechnology Market. We make sure that all the information available in this report has excellent levels of readability. One way we achieve this target is by Food Biotechnology Market segmentation. Going through the report for 2020 2026 will bring our readers up-to-date regarding this industry.

While examining the information from this document, one thing becomes clear, the elements which contribute to increase in demand for the product or service. At the same time, there will be a focus on what drives the popularity of these types of products or services. This report is for those who want to learn about Food Biotechnology Market, along with its forecast for 2020 2026. Information regarding market revenue, competitive partners, and key players will also be available.

Segmentation

As discussed earlier, there is segmentation in the Food Biotechnology Market report, to improve the accuracy and make it easier to collect data. The categories which are the dividing factors in the industry are distribution channels, application, and product or service type. With this level of segmentation, it becomes easier to analyze and understand the Food Biotechnology Market. At the same time, there is emphasis on which type of consumers become the customers in this industry. When it comes to distribution channels, the Food Biotechnology Market report looks at the different techniques of circulation of the product or service.

Regional Overview

In this part of the Food Biotechnology Market report, we will be taking a look at the geographical areas and the role they play in contributing to the growth of this line of business. The areas of interest in this document are as follows Middle East and Africa, South and North America, Europe, and Asia Pacific. From the Food Biotechnology Market report, it becomes clear which region is the largest contributor.

Latest Industry News

From this Food Biotechnology Market report, the reader will also get to learn about the latest developments in the industry. The reason is that these products or services have the potential to disrupt this line of business. If there is information about company acquisitions or mergers, this information will also be available in this portion of the Food Biotechnology Market report.

If you have any special requirements about this Food Biotechnology Market report, please let us know and we can provide custom report.

Inquire more about this report @ https://www.reportsandmarkets.com/enquiry/global-food-biotechnology-market-size-status-and-forecast-2018-2025?utm_source=primefeed&utm_medium=38

About Us

ReportsAndMarkets.com allocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serve our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Contact Us

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

View post:
2020 Impact of COVID-19 on Food Biotechnology Size, Share, Growth, Demand and Forecast to 2026 - Owned

Read More...

Food Biotechnology Market Expected to Witness the Highest Growth 2024 – News.MarketSizeForecasters.com

Monday, July 6th, 2020

Recently, Market Study Report, LLC, added a research on the ' Food Biotechnology market' which encompasses significant inputs with respect to market share, market size, regional landscape, contributing players, and revenue projection of this industry vertical. The report also educates investors regarding the existing tends, prime challenges, and current expansion strategies applied by the key organizations that constitute the hyperactive competitive gamut of this business sphere.

The Food Biotechnology market study report is a detailed analysis of this industry that is evaluated from the perspective of two major parameters - production and consumption. The report, with respect to the production aspect, encompasses details about the manufacturing of the product, its revenue, as well as the gross margins of the manufacturers renowned in the production of the same. The unit costs offered by the producers spanning various geographies between a stipulated timespan are also provided.

Request a sample Report of Food Biotechnology Market at:https://www.marketstudyreport.com/request-a-sample/2524960?utm_source=marketsizeforecasters.com&utm_medium=Ram

Additionally, the study includes information about the consumption aspect. In terms of consumption, details about the product consumption value and product consumption volume are provided. The individual sale price alongside the status of the import and export graphs across various regions have also been provided. In addition, a detailed prediction pertaining to the production and consumption patterns over the forthcoming period has been given.

An overview of the regional landscape:

An outline of the product spectrum:

A gist of the application terrain:

Ask for Discount on Food Biotechnology Market Report at:https://www.marketstudyreport.com/check-for-discount/2524960?utm_source=marketsizeforecasters.com&utm_medium=Ram

An insight into the competitive reach:

The Food Biotechnology market report, in a nutshell, has been broken down into various parts, one of which comprises the basic industry definitions. The analysis on upstream raw materials, downstream consumer base, and equipment has also been carried out and has been duly presented in the report. Additionally, the development trends characterizing this industry in tandem with the marketing channels deployed by the manufacturers have been evaluated and provided suitably.

The Food Biotechnology market research report also plays host to information pertaining to the assessment of the feasibility of new investment projects. The research conclusions inferred from these studies are also accurately presented in the study.

For More Details On this Report: https://www.marketstudyreport.com/reports/global-food-biotechnology-market-professional-survey-2019-by-manufacturers-regions-types-and-applications-forecast-to-2024

Related Reports:

2. Global Electronic Alarm Clock Market Research Report 2019, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026Read More: https://www.marketstudyreport.com/reports/global-electronic-alarm-clock-market-research-report-2019-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

Read More Reports On: https://www.marketwatch.com/press-release/electric-heater-market-outlook-recent-trends-and-growth-forecast-2020-2025-2020-07-02?tesla=y

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

View post:
Food Biotechnology Market Expected to Witness the Highest Growth 2024 - News.MarketSizeForecasters.com

Read More...

Is Entasis Therapeutics Holdings Inc (ETTX) Stock Near the Top of the Biotechnology Industry? – InvestorsObserver

Monday, July 6th, 2020

Entasis Therapeutics Holdings Inc (ETTX) is near the bottom in its industry group according to InvestorsObserver. ETTX gets an overall rating of 38. That means it scores higher than 38 percent of stocks. Entasis Therapeutics Holdings Inc gets a 22 rank in the Biotechnology industry. Biotechnology is number 13 out of 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Entasis Therapeutics Holdings Inc (ETTX) stock is lower by -1.71% while the S&P 500 is unchanged 0% as of 9:53 AM on Monday, Jul 6. ETTX is down -$0.05 from the previous closing price of $2.92 on volume of 164,279 shares. Over the past year the S&P 500 has risen 5.18% while ETTX is down -54.80%. ETTX lost -$3.49 per share the over the last 12 months.

To screen for more stocks like ETTX click here.

See more here:
Is Entasis Therapeutics Holdings Inc (ETTX) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Read More...

Global Agriculture Biotechnology Market Expected to Reach Highest CAGR by 2025 Top Players- : ADAMA Agricultural Solutions, Vilmorin, Bayer,…

Monday, July 6th, 2020

This report on Global Agriculture Biotechnology Market is based on the in-depth view of Agriculture Biotechnology industry on the basis of market growth, market size, development plans and opportunities offered by the global Agriculture Biotechnology market. The report on Agriculture Biotechnology, gives an in-depth analysis of Agriculture Biotechnology market based on aspects that are very important for the market study. Factors like production, market share, revenue rate, regions and key players define a market study start to end. The energetic aspects studied in this report includes SWOT analysis, feasibility and forecast information. For the consumers to gain the in-depth analysis of the global keyword market and further growth of the market, the report offers significant statistics and information. Agriculture Biotechnology report studies the current state of the market to analyze the future opportunities and risks.

This study covers following key players:ADAMA Agricultural SolutionsVilmorinBayerBiocentury TransgeneCertisDow AgroSciencesEurofinsEvogeneGlobal Bio-chem TechnologySyngentaKWS SaatMarina BiotechMonsanto

Request a sample of this report @ https://www.orbismarketreports.com/sample-request/58818?utm_source=Puja

Primarily, the report delivers Agriculture Biotechnology introduction, overview, market objectives, market definition, scope, and market size valuation. Moreover, the report provides historical information with future forecast over the forecast period. Some of the important aspects analyzed in the report includes market share, production, key regions, revenue rate as well as key players. The Agriculture Biotechnology market has its impact all over the globe. On global level Agriculture Biotechnology industry is segmented on the basis of product type, applications, and regions. It also focusses on market dynamics, Agriculture Biotechnology growth drivers, developing market segments and the market growth curve is offered based on past, present and future market data. The industry plans, news, and policies are presented at a global and regional level.

Access Complete Report @ https://www.orbismarketreports.com/global-agriculture-biotechnology-market-size-status-and-forecast-2019-2025?utm_source=Puja

Market segment by Type, the product can be split into BiochipsDeoxy ribonucleic acid (DNS) sequencingGenome editing toolsRibonucleic acid interference (RNAI)Synthetic biology

Market segment by Application, split into Transgenic crops marketSynthetic biology-enabled products market

This Agriculture Biotechnology report also provides the readers with detailed figures at which the Agriculture Biotechnology market was valued in the historical year and its expected growth in upcoming years. Besides, analysis also forecasts the CAGR at which the Agriculture Biotechnology is expected to mount and major factors driving markets growth. The study on global Agriculture Biotechnology market, offers deep insights about the Agriculture Biotechnology market covering all the crucial aspects of the market.In addition, the report include deep dive analysis of the market, which is one of the most important features of the market. Furthermore, the need for making an impact is likely to boost the demand for the experts which are working in the market. Moreover, an in depth analysis of the competitors is also done to have an estimate for the market.

Some Major TOC Points:1 Report Overview2 Global Growth Trends3 Market Share by Key Players4 Breakdown Data by Type and ApplicationContinued

The Agriculture Biotechnology research study is a helpful analysis which emphasizing on geographical analysis, primary & secondary research methodologies, market drivers, and leading segmentation and sub-segments analysis. With the whole overview of the Agriculture Biotechnology market, the studyprovides the overall viability of future projects and delivers the Agriculture Biotechnology report conclusion. The Agriculture Biotechnology market report also delivers market evaluationalong with the PESTEL, SWOT, and other necessary data. In addition, the Agriculture Biotechnology market study categorizes the global market data by using numerous factors such as application, region, manufacturers, and type.

For Enquiry before buying report @ https://www.orbismarketreports.com/enquiry-before-buying/58818?utm_source=Puja

About Us : With unfailing market gauging skills, has been excelling in curating tailored business intelligence data across industry verticals. Constantly thriving to expand our skill development, our strength lies in dedicated intellectuals with dynamic problem solving intent, ever willing to mold boundaries to scale heights in market interpretation.

Contact Us : Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Here is the original post:
Global Agriculture Biotechnology Market Expected to Reach Highest CAGR by 2025 Top Players- : ADAMA Agricultural Solutions, Vilmorin, Bayer,...

Read More...

Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results – BioSpace

Monday, July 6th, 2020

SOUTH SAN FRANCISCO, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report second quarter 2020 financial results on Thursday, August 6, 2020, after the close of the market.

Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host a conference call and webcast at 2:00 p.m. PT, 5:00 p.m. ET, on August 6, 2020, to discuss second quarter 2020 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call.

Individuals interested in listening to the conference call may do so by dialing:

US domestic callers: (877) 556-5248Outside US callers: (720) 545-0029Please reference Conference ID: 2068836

A live webcast of the conference call will be available online from the Investor Relations page of the Companys website at Events & Presentations. The link will not be active until 1:45 p.m. PT, 4:45 p.m. ET, on August 6, 2020.

After the live webcast, the call will be archived on Fluidigms Investor Relations page at investors.fluidigm.com. In addition, a telephone replay of the teleconference will be available approximately 90 minutes after the end of the call.

The replay dial-in numbers are:

US domestic callers: (855) 859-2056Outside US: (404) 537-3406Please reference Conference ID: 2068836

The telephone replay will be available until August 13.

About FluidigmFluidigm(Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, and plant and animal research laboratories worldwide. Together with them, we strive to increase the quality of life for all. For more information, visitfluidigm.com.

Fluidigm, theFluidigmlogo, and CyTOF are trademarks and/or registered trademarks ofFluidigm Corporationinthe United Statesand/or other countries. All other trademarks are the sole property of their respective owners. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Available InformationWe use our website (fluidigm.com), investor site (investors.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm), and LinkedIn page (linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases,SECfilings, public conference calls, and webcasts.

Contact:

Agnes LeeVice President, Investor Relations650 416 7423agnes.lee@fluidigm.com

View post:
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results - BioSpace

Read More...

Cell Expansion Market Worth $30.1 billion by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

Monday, July 6th, 2020

CHICAGO, July 6, 2020 /PRNewswire/ -- According to the new market research report "Cell Expansion Marketby Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025", published by MarketsandMarkets,the Cell Expansion Marketis estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

Growth in this market is primarily driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.

The media segment accounted for the largest share of the consumables segment in the Cell Expansion Market

Based on product type, consumables are segmented into media, reagents, sera, and disposables. The media segment accounted for the largest share of the consumables segment in the market. The large share of this segment can be attributed to its high requirement during the production of pharmaceutical products and rising R&D investments on cell-based therapies.

Browsein-depth TOC on"Cell Expansion Market"

595 Tables 33 Figures354 Pages

Biotechnology & biopharmaceutical companies accounted for the fastest-growing end user segment of the market

Based on end-users, the market has been segmented into research institutes, biotechnology & biopharmaceutical companies, cell banks, and other end users (includes hospitals, diagnostic centers, and laboratories). In 2019, biotechnology & biopharmaceutical companies were the largest end-users in the Cell Expansion Market, and the trend is the same throughout the forecast period. Increasing production of regenerative medicine and rising awareness regarding advanced treatment methods such as personalized medicines and other cell-based therapies are the major driving factors for this segment.

North America accounted for the largest share of the market

North America accounted for the largest share of the market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, increasing geriatric population, and the strong presence of industry players in the region.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883

Some of the leading players in the Cell Expansion Market include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany)

Browse Adjacent Markets:Biotechnology Market Research Reports & Consulting

Get Special Pricing on Bundle Reports:

https://www.marketsandmarkets.com/RequestBundleReport.asp?id=194978883

Browse Related Reports:

Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/cell-isolation-market-103931479.html

3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected] Visit Our Website: https://www.marketsandmarkets.comResearch Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-expansion-market.aspContent Source: https://www.marketsandmarkets.com/PressReleases/cell-expansion.asp

SOURCE MarketsandMarkets

Go here to see the original:
Cell Expansion Market Worth $30.1 billion by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire

Read More...

White Biotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2025 – Daily Research Chronicles

Monday, July 6th, 2020

The White Biotechnology Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the White Biotechnology market report provides authentic and reliable estimates for the forecast period. The Best part of this report is, this analyses the current state where all are fighting with the COVID-19, The report also provides the market impact and new opportunities created due to the Covid19 catastrophe.

Leading Companies Reviewed in the Report are:

Solazyme Inc., Novozymes, Global Bioenergies, Amyris, BioAmber, Metabolic Explorer, Deinove, Evolva, Fermentlag, Codexis and many more

Get Exclusive Sample of Report on White Biotechnology market is available @ https://www.adroitmarketresearch.com/contacts/request-sample/117

The prime objective of this report is to help the user to gain a complete knowledge of the market in terms of its definition, segmentation, influential trends, market potential, and the challenges that the market is facing. The White Biotechnology Market report offers recorded market information from 2015 to 2019, reveals revenue estimations for 2020 and figures from 2020 till 2025

White Biotechnology Market highlights industry essentials, regional market, global economic industry growth, and market competitors along with their market share. White Biotechnology Market report is concluded through collecting the number of researches. Sever industry based analytical techniques were also analyzed for a better understanding of this market.

Quick Read Table of Contents of this Report @ https://www.adroitmarketresearch.com/industry-reports/white-biotechnology-market

White Biotechnology market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

In addition, the number of business tactics aids the White Biotechnology market players to give competition to the other players in the market while recognizing the significant growth prospects. Likewise, the research report includes significant information regarding the market segmentation which is designed by primary and secondary research techniques. It also offers a complete data analysis about the current trends which have developed and are expected to become one of the strongest White Biotechnology market forces into coming future. In addition to this, the White Biotechnology report provides the extensive analysis of the market restraints that are responsible for hampering the White Biotechnology market growth along with the report also offers a comprehensive description of each and every aspects and its influence on the keyword market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/117

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414

Read more here:
White Biotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2025 - Daily Research Chronicles

Read More...

Blue Biotechnology Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Monday, July 6th, 2020

New Jersey, United States,- Market Research Intellect sheds light on the market scope, potential, and performance perspective of the Global Blue Biotechnology Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the global Blue Biotechnology market.

The research study includes the latest updates about the COVID-19 impact on the Blue Biotechnology sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Blue Biotechnology manufacturers/companies operating at both regional and global levels:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=375159&utm_source=3WN&utm_medium=888

The Blue Biotechnology market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Blue Biotechnology market.

This study analyzes the growth of Blue Biotechnology based on the present, past and futuristic data and will render complete information about the Blue Biotechnology industry to the market-leading industry players that will guide the direction of the Blue Biotechnology market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Blue Biotechnology market. Additionally, it includes a share of each segment of the Blue Biotechnology market, giving methodical information about types and applications of the market.

Reasons for Buying Blue Biotechnology Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Blue Biotechnology market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=375159&utm_source=3WN&utm_medium=888

In the end, the Blue Biotechnology market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Blue Biotechnology market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Industrial Networking Solutions Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Location-Based Services (LBS) And Real-Time Location Systems (RTLS) Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Middle East & Africa Cloud Infrastructure Services Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Middle East & Africa Cybersecurity Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Point-Of-Care Diagnostics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Read more here:
Blue Biotechnology Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read More...

The Largest Biotech Companies In The World – WorldAtlas

Friday, July 3rd, 2020

By Amber Pariona on April 25 2017 in Economics

Biotechnology is the use of advances in life sciences in the production of marketable goods. A biotech company, therefore, is an enterprise that produces products and services by utilizing biotechnology. Many biotech companies exist around the world. This article takes a look at some of the largest biotech companies according to market capitalization values.

The largest biotech company in the world is Johnson & Johnson, founded in 1885 as a provider of ready-to-use surgical dressings. Today, this company is a multinational pharmaceutical, medical devices, and first aid supplies manufacturer. Some of the most well known Johnson & Johnson brands include: Tylenol, Neutrogena, Band-Aid, Acuvue contact lenses, and Clear and Clear. It operates in 60 countries with sales in more than 175 countries and headquarters in New Brunswick in the US state of New Jersey. It employs approximately 127,100 individuals and had global sales of around $70.1 billion in 2015. In 2016, Johnson & Johnson had a market capitalization of $314.1 billion.

Pfizer is the second largest biotech company in the world. It was founded in 1849 as a chemicals company and began to grow significantly in the 1880s after producing and selling citric acid. Today, Pfizer is a global pharmaceutical company that specializes in vaccines and medicines for a wide range of health fields, including: oncology, immunology, diabetology, neurology, and cardiology. Some of its most well known brands areCelebrex, and Lipitor. Its corporate headquarters are in New York City, with research headquarters in Groton in the US state of Connecticut. This company has approximately 78,300 employees and had a 2015 revenue rate of $48.85 billion. In 2016, Pfizer had a market capitalization of $196.3 billion.

The third largest biotech company in the world is Roche, founded in 1896 as a provider of vitamins. It was the first company in the world to mass-produce synthetic vitamin C. Today, it is a multinational pharmaceuticals and diagnostics healthcare company. Some of the most well-known Roche products include: Valium, Bactrim, Avastin, and Naprosyn. Its headquarters are located in the city of Basel in Switzerland. Over the years, Roche has acquired a number of biotechnology companies with the most recent being Tensha Therapeutics for $115 million, announced in January of 2016. This company has around 88,509 employees and a 2014 revenue rate of $47.65 billion. In 2016, Roche had a market capitalization of $192.1 billion.

Novartis is the fourth largest biotech company in the world. It was founded in 1996 after a merger between Ciba-Geigy and Sandoz Laboratories. It is a multinational pharmaceutical company with headquarters in Basel, Switzerland that produces a number of drugs, consumer health products, and animal health products (for pets and livestock). Some of its most well-known pharmaceuticals include: Diclofenac, Clozapine, Letrozole, and Ciclosporin. Novartis is a member of the International Federation of Pharmaceutical Manufacturers and Associations, the Pharmaceutical Research and Manufacturers of America, and the European Federation of Pharmaceutical Industries and Associations. This company employs 118,700 individuals around the world and in 2015, had a revenue of $50.359. In 2016, Novartis had a market capitalization of $170.5 billion.

The chart published below provides a more complete list of the largest biotech companies in the world.

See more here:
The Largest Biotech Companies In The World - WorldAtlas

Read More...

Importance Of Biotechnology | My Essay Point

Friday, July 3rd, 2020

Biotechnology is a technology based on biology. This article talks about the importance of biotechnology in our lives.

The world we have live has been suffering for so long and humanity is facing an enormous problem on the excessive usage of natural resources. The energy we have been purging from these resources is diminishing and is now critically endangered for future use. Not only that but sudden changes to our environment brought tragedies and disaster that leaves mark for a lifetime. People has intelligently abuse our nature.

Its strange to know that most of the educated people regardless of gender are unaware of the importance of biotechnology in any aspects of our society, even though it is crystal clear that its technological value has foreseen for a long time to motivate the upcoming generations. It is certain that human existence and survival on the coming days rest on the development and rapidly advancement of biotechnology.

Because of the advancement of thorough researched and development, the importance of biotechnology has come to existence. It is a field in biology that is extensively used in engineering, medicine, science and technology, agriculture and other valuable form of applications. Biotechnology can be a great solution to mankind struggles. So, what does its all about? Briefly, it is merely an applied principles of chemistry, physics and engineering comprise into biological structure.

Application in modern era includes the field of genetic engineering. It is the usage of this technology to culture cells and tissues for the modification living organism for human purposes. By this, the importance of biotechnology in agriculture increases the crop production which makes it double or even higher than normal harvest. It has the ability to give biological protection from disease and pests, so a minor necessity for chemical insecticides. Biotechnology is capable of conveying genetic qualities of the crops that can withstand the changing climate condition, obtain an increase of nutritional qualities. This will provide the farmers a healthy lifestyle due to the less exposure of chemical residues and eventually give a higher profit.

Benefits of biotechnology can also be experienced in the medical institution. Its technological application includes pharmaceutical products and medicines, and human therapy. It helps produced large quantity of protein for nutritional supplements and insulin for diabetic patient treatment. The gene therapy, in which is the most successful result of biotechnology research use to cure aids and cancer.

Application on biotechnology can be seen in industrial plant and factories. They are used to give an improved effectiveness and competence in production process while reducing the impact to the environmental issues. Waste products can be treated and recycled as a help to preserve natural resources.

It is beyond expectation on what the biotechnology has accomplished and reached in just a matter of time. Humanity has just start to comprehend and recognized the endless opportunities it has open. As technology assures to provide solution to every frightening problem we face every now and then, so is mankind is expecting a more develop biotechnology in the future. A technology that is more reliable and firm. This is the importance of biotechnology; revolution of the future technology.

Do share your thoughts on Importance of Biotechnology in the comments below.

More here:
Importance Of Biotechnology | My Essay Point

Read More...

Biotechnology, B.S. & Penn State

Friday, July 3rd, 2020

Program Description

Biotechnology may be broadly defined as the application of principles of molecular and cell science in the production of biologically important or industrially useful products. Therefore, students in the Biotechnology major will

One very important strength of this major is the extensive laboratory experience each student receives. In the General option, students are very strongly encouraged to consider Cooperative Education with industry as an integral part of their curriculum. In addition to the General option in Biotechnology, the major also offers the Clinical Laboratory Science option.

Biotechnology is broadly defined as the application of principles of molecular and cell science to the production of biologically important or industrially useful products. Topics in biotechnology include genetic engineering, pharmaceutical development, and bio-manufacturing.

In order to be eligible for entrance to the Biotechnology major, a student must have:

For the Bachelor of Science degree in Biotechnology, a minimum of 125 credits is required:

15 of the 45 credits for General Education are included in the Requirements for the Major.This includes: 9 credits of GN courses; 6 credits of GQ courses.

Connecting career and curiosity, the General Education curriculum provides the opportunity for students to acquire transferable skills necessary to be successful in the future and to thrive while living in interconnected contexts. General Education aids students in developing intellectual curiosity, a strengthened ability to think, and a deeper sense of aesthetic appreciation. These are requirements for all baccalaureate students and are often partially incorporated into the requirements of a program. For additional information, see the General Education Requirements section of the Bulletin and consult your academic adviser.

The keystone symbol appears next to the title of any course that is designated as a General Education course. Program requirements may also satisfy General Education requirements and vary for each program.

All students enrolled in a college or the Division of Undergraduate Studies at University Park, and the World Campus are required to take 1 to 3 credits of the First-Year Seminar, as specified by their college First-Year Engagement Plan.

Other Penn State colleges and campuses may require the First-Year Seminar; colleges and campuses that do not require a First-Year Seminar provide students with a first-year engagement experience.

First-year baccalaureate students entering Penn State should consult their academic adviser for these requirements.

6 credits are required and may satisfy other requirements

3 credits required from the college of graduation and likely prescribed as part of major requirements.

A minimum of 120 degree credits must be earned for a baccalaureate degree. The requirements for some programs may exceed 120 credits. Students should consult with their college or department adviser for information on specific credit requirements.

Candidates must complete the degree requirements for their major and earn at least a 2.00 grade-point average for all courses completed within their degree program.

The college dean or campus chancellor and program faculty may require up to 24 credits of course work in the major to be taken at the location or in the college or program where the degree is earned. Credit used toward degree programs may need to be earned from a particular source or within time constraints (see Senate Policy 83-80). For more information, check the Suggested Academic Plan for your intended program.

To graduate with a B.S. degree in Biotechnology, a grade of C or better is required in 9 credits of any BIOTC, B M B, or MICRB 400-level course except BMB442, BMB443W, BMB445W, BMB448, BMB488, BMB496, MICRB421W, MICRB422, MICRB447.

To graduate, a student enrolled in the major must earn a grade of C or better in each course designated by the major as a C-required course, as specified by Senate Policy 82-44.

This option provides both the academic and clinical preparation for students interested in a career as a clinical laboratory scientist. Positions are found in hospital, physician-office, reference, industrial, and research laboratories. To complete baccalaureate degree requirements, students enter a ten-month clinical practicum (MICRB405A, MICRB405B, MICRB405C, MICRB405D, MICRB405E, MICRB405F) at an affiliate hospital for the senior year. (Current affiliations are with Mount Nittany Medical Center, State College and Pennsylvania Hospital, Philadelphia.) Students are recommended for a fixed number of hospital positions on a competitive basis. Cumulative grade-point average and hospital school admission requirements serve as criteria for recommendation. The B.S. degree is awarded at the first commencement following completion of the clinical practicum.

PROFESSOR Loida Escote-Carlson, in charge

The integrated B.S. in Biotechnology-Master of Biotechnology degree program is designed to enable qualified undergraduate students in the B.S. Biotechnology program to graduate in five years with the Master of Biotechnology degree. The requirements of the Master of Biotechnology degree are designed to prepare students for diverse career opportunities in the burgeoning biotechnology industry. The integrated B.S. Biotechnology-Master of Biotechnology program will enhance the preparation and qualifications of B.S. Biotechnology students seeking entry-level positions in biotechnology and related industries. At the same time, students develop a practical knowledge of the laboratory techniques that underlie current research in the life sciences that will serve as excellent preparation for those students in the Master of Biotechnology program who later decide to pursue further graduate degrees.

A maximum of 12 credits will be cross-counted towards the B.S. and Masters degrees, from the following courses:

Total credits required: 125GENERAL EDUCATION: 46 credits (15 of these are included in the REQUIREMENTS FOR THE MAJOR)REQUIREMENTS FOR THE MAJOR: 94-95 creditsPrescribed courses: 67 creditsAdditional courses: 6-9 creditsSupporting courses and related areas: 18-21 credits

Total credits required: 30 (18 of which must be from 500-level courses)Required courses: 16-19 creditsElectives: 11-14 credits

The objectives of the universitys academic advising program are to help advisees identify and achieve their academic goals, to promote their intellectual discovery, and to encourage students to take advantage of both in-and out-of class educational opportunities in order that they become self-directed learners and decision makers.

Both advisers and advisees share responsibility for making the advising relationship succeed. By encouraging their advisees to become engaged in their education, to meet their educational goals, and to develop the habit of learning, advisers assume a significant educational role. The advisees unit of enrollment will provide each advisee with a primary academic adviser, the information needed to plan the chosen program of study, and referrals to other specialized resources.

READ SENATE POLICY 32-00: ADVISING POLICY

Jennifer KeeferAcademic Adviser239 Ritenour BuildingUniversity Park, PA 16802814-863-5487jls227@psu.edu

The suggested academic plan(s) listed on this page are the plan(s) that are in effect during the 2020-21 academic year. To access previous years' suggested academic plans, please visit the archive to view the appropriate Undergraduate Bulletin edition (Note: the archive only contain suggested academic plans beginning with the 2018-19 edition of the Undergraduate Bulletin).

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

This major has two options: Clinical Laboratory Option or General Option. Graduates from the General option frequently accept positions in the bio-pharmaceutical industry or with newly-emerging biotechnology companies bringing new products to market. Graduates from the Clinical Lab Science Option are prepared to complete the certification exam necessary to work as a Medical Laboratory Scientist in a hospital or other medical laboratory.

A BS in Biotechnology prepares students for a wide variety of careers, including industry, health related professions, and careers in academic or government labs. Examples of biotechnology related careers are:

Many students with a BS in Biotechnology will pursue graduate education in biotechnology, management, policy or other related disciplines. Penn State students interested in pursuing a MS in Biotechnology can enroll in the integrated undergraduate graduate (IUG) program. IUG students complete a BS and MS with 5 years of coursework, which includes a nine-month internship in industry, government or academia. A BS in Biotechnology also prepares students to pursue higher degrees in the health professions. Opportunities for graduate studies include, but are not limited to, the following:

MORE INFORMATION ABOUT OPPORTUNITIES FOR GRADUATE STUDIES

The rest is here:
Biotechnology, B.S. & Penn State

Read More...

Pharmaceutical and Biotechnology Environmental Monitoring Market | Trends, Comprehensive Research Study, Sales Revenue, Development Status, Company…

Friday, July 3rd, 2020

Pharmaceutical and Biotechnology Environmental Monitoring Market has witnessed continuous growth within the past few years and is projected to grow even more throughout the forecast period (2020 2027). The analysis presents a whole assessment of the market and contains Future trends, Current Growth Factors, attentive opinions, facts, historical information, and statistically supported and trade valid market information.

The report, titled Global Pharmaceutical and Biotechnology Environmental Monitoring Market defines and briefs readers about its products, applications, and specifications. The research lists key companies operating in the global market and also highlights the key changing trends adopted by the companies to maintain their dominance. By using SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and threats of key companies are all mentioned in the report. All leading players in this global market are profiled with details such as product types, business overview, sales, manufacturing base, competitors, applications, and specifications.

You Can Request A Demo Version of Report Before Buying (Higher Preference For Corporate Email ID User): https://www.worldwidemarketreports.com/sample/270219

Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Eurofins Sinensis, Lonza, Biomerieux, VAI, Cosasco of the major organizations dominating the global market.(*Note: Other Players Can be Added per Request)

1. Industry outlookThis is where youll find the current state of the Pharmaceutical and Biotechnology Environmental Monitoring industry overall and where its headed. Relevant industry metrics like size, trends, life cycle, and projected growth included here. This report comes prepared with the data to back up your business idea. On a regional basis, the Global Pharmaceutical and Biotechnology Environmental Monitoring market has been segmented into Asia-Pacific, North America, Europe, Latin America, and the Middle East and Africa.

2. Target marketThis target market section of study includes the following:

User persona and characteristics: It includes demographics such as age, income, and location. It lets you know what their interests and buying habits are, as well as explain the best position to meet their needs.

Market size: How big is the potential Pharmaceutical and Biotechnology Environmental Monitoring market for your business? It brings to light the consumption in the Pharmaceutical and Biotechnology Environmental Monitoring industry by the type and application.

3. Competitive analysisDiscover your competitors. The report lets you know what youre up against, but it also lets you spot the competitions weaknesses. Are there customers that are underserved? What can you offer that similar businesses arent offering? The competitive analysis contains the following components:

Direct competitors: What other companies are offering similar products and services? Which companies are your true competitors?

Competitor strengths and weaknesses: What is your competition good at? Where do they fall behind? Get insights to spot opportunities to excel where others are falling short.

Barriers to entry: What are the potential pitfalls of entering the Pharmaceutical and Biotechnology Environmental Monitoring market? Whats the cost of entry? Is it prohibitively high, or easy to enter?

The window of opportunity:Does your entry into the Pharmaceutical and Biotechnology Environmental Monitoring industry rely on time-sensitive technology? Do you need to enter early to take advantage of an emerging market?

4. ProjectionsLikewise, We offered thoughtful, not hockey-stick forecasting.

Market share:We have given the consumption behavior of users. When you know how much can your future customers spend, then only youll understand how much of the Pharmaceutical and Biotechnology Environmental Monitoring industry you have a chance to grab, and here we came up with real stats and numbers.

Impact Analysis of COVID-19:The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into account the political, economic, social, and technological parameters.

Finally, It is one report that hasnt shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of the Pharmaceutical and Biotechnology Environmental Monitoring Industry, per application. Most noteworthy, this market analysis will help you find market blind spots.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: [emailprotected]

Visit link:
Pharmaceutical and Biotechnology Environmental Monitoring Market | Trends, Comprehensive Research Study, Sales Revenue, Development Status, Company...

Read More...

Plant Biotechnology Services Market 2020 Opportunities, Growth Analysis, Trends and Forecast by 2024 | Thermo Fisher Scientific Inc., Agilent…

Friday, July 3rd, 2020

Competitive Market Research Report on Global Plant Biotechnology Services Market with focus on Industry Analysis, Growth Opportunities, Risk Analysis, Current Trends, Competitive Landscape, Investment Strategies and Forecast by 2024.

The report contains in-depth information on all the key aspects of the global Plant Biotechnology Services market. This report contains important data such as facts & figures, market research, market analysis, SWOT analysis, competitive landscape, regional analysis and future growth prospects. The report also contains qualitative and quantitative research which gives you a detailed analysis of the global Plant Biotechnology Services market. The report is perfect as you can see information on the recent developments, based on which you can make risk assessments and investments in the Plant Biotechnology Services industry.

Get The Sample Report PDF with Detail TOC & List of [emailprotected]https://marketresearchport.com/request-sample/5075

Leading Companies Covered:

Thermo Fisher Scientific Inc., Agilent Technologies, GenScript Biotech Corporation, Eurofins Scientific SE

This global Plant Biotechnology Services market research report has data of all the leading players operating in the industry. From their market shares in the industry, to their growth plans, recent development status, all important information has been compiled in the report to let you get an insightful look at the top players operating in the industry. The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.

Market Research is Further Divided into Following Segments:

Market Segmentation by Product Types:Genomics Services, Analytical Chemistry, Cellular Imaging, Forage Analysis, Transformation Services

Market Segmentation by Applications:Research Institutes, Pharmaceuticals Companies, Biotechnology Companies

Regions Mentioned in the Global Plant Biotechnology Services Market:

The Middle East and Africa North America South America Europe Asia-Pacific Middle East Oceania Rest of the World

The data of the market research report has been studied, compiled and corroborated by leading industry experts and established authors. The format followed in the report is in accordance with most international market research reports. However, if you have any specific requirements, just get in touch with us, and we will customize the report accordingly as per your needs.

Do Enquiry For Customized Report as per Your [emailprotected]https://marketresearchport.com/enquiry-before-buying/5075

Table of Content:1 Industry Overview of Plant Biotechnology Services1.1 Brief Introduction of Plant Biotechnology Services1.1.1 Definition of Plant Biotechnology Services1.1.2 Development of Plant Biotechnology Services Industry1.2 Classification of Plant Biotechnology Services1.3 Status of Plant Biotechnology Services Industry1.3.1 Industry Overview of Plant Biotechnology Services1.3.2 Global Major Regions Status of Plant Biotechnology Services

2 Industry Chain Analysis of Plant Biotechnology Services2.1 Supply Chain Relationship Analysis of Plant Biotechnology Services2.2 Upstream Major Raw Materials and Price Analysis of Plant Biotechnology Services2.3 Downstream Applications of Plant Biotechnology Services

3 Manufacturing Technology of Plant Biotechnology Services3.1 Development of Plant Biotechnology Services Manufacturing Technology3.2 Manufacturing Process Analysis of Plant Biotechnology Services3.3 Trends of Plant Biotechnology Services Manufacturing Technology

4 Major Manufacturers Analysis of Plant Biotechnology Services4.1 Company 14.1.1 Company Profile4.1.2 Product Picture and Specifications4.1.3 Capacity, Production, Price, Cost, Gross and Revenue4.1.4 Contact Information4.2 Company 24.2.1 Company Profile4.2.2 Product Picture and Specifications4.2.3 Capacity, Production, Price, Cost, Gross and Revenue4.2.4 Contact Information4.3 Company 34.3.1 Company Profile4.3.2 Product Picture and Specifications4.3.3 Capacity, Production, Price, Cost, Gross and Revenue4.3.4 Contact Information4.4 Company 44.4.1 Company Profile4.4.2 Product Picture and Specifications4.4.3 Capacity, Production, Price, Cost, Gross and Revenue4.4.4 Contact Information4.5 Company 54.5.1 Company Profile4.5.2 Product Picture and Specifications4.5.3 Capacity, Production, Price, Cost, Gross and Revenue4.5.4 Contact Information4.6 Company 64.6.1 Company Profile4.6.2 Product Picture and Specifications4.6.3 Capacity, Production, Price, Cost, Gross and Revenue4.6.4 Contact Information4.7 Company 74.7.1 Company Profile4.7.2 Product Picture and Specifications4.7.3 Capacity, Production, Price, Cost, Gross and Revenue4.7.4 Contact Information4.8 Company 84.8.1 Company Profile4.8.2 Product Picture and Specifications4.8.3 Capacity, Production, Price, Cost, Gross and Revenue4.8.4 Contact Information4.9 Company 94.9.1 Company Profile4.9.2 Product Picture and Specifications4.9.3 Capacity, Production, Price, Cost, Gross and Revenue4.9.4 Contact Information4.10 Company ten4.10.1 Company Profile4.10.2 Product Picture and Specifications4.10.3 Capacity, Production, Price, Cost, Gross and Revenue4.10.4 Contact Information

5 Global Productions, Revenue and Price Analysis of Plant Biotechnology Services by Regions, Manufacturers, Types and Applications5.1 Global Production, Revenue of Plant Biotechnology Services by Regions 2014-20195.2 Global Production, Revenue of Plant Biotechnology Services by Manufacturers 2014-20195.3 Global Production, Revenue of Plant Biotechnology Services by Types 2014-20195.4 Global Production, Revenue of Plant Biotechnology Services by Applications 2014-20195.5 Price Analysis of Global Plant Biotechnology Services by Regions, Manufacturers, Types and Applications in 2014-2019

6 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Plant Biotechnology Services 2014-20196.1 Global Capacity, Production, Price, Cost, Revenue, of Plant Biotechnology Services 2014-20196.2 Asia Pacific Capacity, Production, Price, Cost, Revenue, of Plant Biotechnology Services 2014-20196.3 Europe Capacity, Production, Price, Cost, Revenue, of Plant Biotechnology Services 2014-20196.4 Middle East & Africa Capacity, Production, Price, Cost, Revenue, of Plant Biotechnology Services 2014-20196.5 North America Capacity, Production, Price, Cost, Revenue, of Plant Biotechnology Services 2014-20196.6 Latin America Capacity, Production, Price, Cost, Revenue, of Plant Biotechnology Services 2014-2019

7 Consumption Volumes, Consumption Value, Import, Export and Sale Price Analysis of Plant Biotechnology Services by Regions7.1 Global Consumption Volume and Consumption Value of Plant Biotechnology Services by Regions 2014-20197.2 Global Consumption Volume, Consumption Value and Growth Rate of Plant Biotechnology Services 2014-20197.3 Asia Pacific Consumption Volume, Consumption Value, Import, Export and Growth Rate of Plant Biotechnology Services 2014-20197.4 Europe Consumption Volume, Consumption Value, Import, Export and Growth Rate of Plant Biotechnology Services 2014-20197.5 Middle East & Africa Consumption Volume, Consumption Value, Import, Export and Growth Rate of Plant Biotechnology Services 2014-20197.6 North America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Plant Biotechnology Services 2014-20197.7 Latin America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Plant Biotechnology Services 2014-20197.8 Sale Price Analysis of Global Plant Biotechnology Services by Regions 2014-2019

8 Gross and Gross Margin Analysis of Plant Biotechnology Services8.1 Global Gross and Gross Margin of Plant Biotechnology Services by Regions 2014-20198.2 Global Gross and Gross Margin of Plant Biotechnology Services by Manufacturers 2014-20198.3 Global Gross and Gross Margin of Plant Biotechnology Services by Types 2014-20198.4 Global Gross and Gross Margin of Plant Biotechnology Services by Applications 2014-2019

9 Marketing Traders or Distributor Analysis of Plant Biotechnology Services9.1 Marketing Channels Status of Plant Biotechnology Services9.2 Marketing Channels Characteristic of Plant Biotechnology Services9.3 Marketing Channels Development Trend of Plant Biotechnology Services

10 Global and Chinese Economic Impacts on Plant Biotechnology Services Industry10.1 Global and Chinese Macroeconomic Environment Analysis10.1.1 Global Macroeconomic Analysis and Outlook10.1.2 Chinese Macroeconomic Analysis and Outlook10.2 Effects to Plant Biotechnology Services Industry

11 Development Trend Analysis of Plant Biotechnology Services11.1 Capacity, Production and Revenue Forecast of Plant Biotechnology Services by Regions, Types and Applications11.1.1 Global Capacity, Production and Revenue of Plant Biotechnology Services by Regions 2019-202411.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Plant Biotechnology Services 2019-202411.1.3 Global Capacity, Production and Revenue of Plant Biotechnology Services by Types 2019-202411.2 Consumption Volume and Consumption Value Forecast of Plant Biotechnology Services by Regions11.2.1 Global Consumption Volume and Consumption Value of Plant Biotechnology Services by Regions 2019-202411.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Plant Biotechnology Services 2019-202411.3 Supply, Import, Export and Consumption Forecast of Plant Biotechnology Services11.3.1 Supply, Consumption and Gap of Plant Biotechnology Services 2019-202411.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Plant Biotechnology Services 2019-202411.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Plant Biotechnology Services 2019-202411.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Plant Biotechnology Services 2019-202411.3.5 Asia Pacific Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Plant Biotechnology Services 2019-202411.3.6 Middle East & Africa Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Plant Biotechnology Services 2019-202411.3.7 Latin America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Plant Biotechnology Services 2019-2024

12 Contact information of Plant Biotechnology Services12.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Plant Biotechnology Services12.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Plant Biotechnology Services12.1.2 Major Equipment Suppliers with Contact Information Analysis of Plant Biotechnology Services12.2 Downstream Major Consumers Analysis of Plant Biotechnology Services12.3 Major Suppliers of Plant Biotechnology Services with Contact Information12.4 Supply Chain Relationship Analysis of Plant Biotechnology Services

13 New Project Investment Feasibility Analysis of Plant Biotechnology Services13.1 New Project SWOT Analysis of Plant Biotechnology Services13.2 New Project Investment Feasibility Analysis of Plant Biotechnology Services13.2.1 Project Name13.2.2 Investment Budget13.2.3 Project Product Solutions13.2.4 Project Schedule

14 Conclusion of the Global Plant Biotechnology Services Industry 2019 Market Research Report

About Us:Market Research Port is one of the best report resellers in the market bringing to you accurate and trustworthy market research reports by reputed publishers. Our trusted publishers have compiled their reports and findings after painstaking research and studies, set up against varied business parameters. Each report is detailed and then vetted for accuracy by industry experts. In each report, you will find deep analysis, risk analysis, market forecasts, emerging trends, different market segments, technological advancement and its impact, and a multitude of economic factors, giving you the most comprehensive market research report. You get many advantages with such comprehensive reports.

Contact Us:Market Research Port,Brighton Street, Providence,Rhode Island 02929, United StatesContact No: +1 401 433 7610Email: [emailprotected]Website: https://marketresearchport.com/

Visit link:
Plant Biotechnology Services Market 2020 Opportunities, Growth Analysis, Trends and Forecast by 2024 | Thermo Fisher Scientific Inc., Agilent...

Read More...

Global Biotechnology Market 2020 COVID-19 Impact, Share, Trend, Segmentation and Forecast to 2026 – 3rd Watch News

Friday, July 3rd, 2020

Biotechnology Market:

WiseGuyReports.com addsGlobal Biotechnology Market Research Report 2020 Analysis and Forecast 2026reportsto itsdatabase.

Executive Summary

The report lays out a detailed form of database with regard to the recent discoveries and the key technological advancements in the industry, along with the assessment of the impact that these developments can have on the growth prospects of the market. The report primarily focuses on the business conditions coupled with the potential headways as well as the entryways in the global Biotechnology market. In addition to this, the main objective is to present the current price margins along with the challenges that can potentially be faced by the manufacturers during the review period. The continually changing dynamics in the market have also been appraised by the experts. In summary, the report throws light on the market status throughout the forecast period, which starts with 2020, and ends with 2026.

Request Free Sample Report @https://www.wiseguyreports.com/sample-request/5506311-covid-19-impact-on-global-biotechnology-market-size-status-and-forecast-2020-2026

Primary Boosters & Challenges

Apart from offering an in-depth appraisal of the main dynamics that mold the Biotechnology market, the report also outlines the pricing record, volume trends and the market size in the coming years. The significant opportunities, challenges along with the primary boosters are also outlined in the report, for providing an enhanced comprehension of the market.

Regional Study

The opportunities, threats, inadequacies and strengths in the Biotechnology market have been elucidated in the report, with respect to certain regions. Across these regions, the renowned players are working on boosting their profits armed with strategies such as agreements, partnerships and more. The Biotechnology markets regional study comprises the latest valuation as well as the future growth possibilities. The key regional markets assessed in the report include the Middle East & Africa, Europe, Latin America, North America and Asia Pacific. The oncoming and the latest trends combined with the market size across these regions are provided in this section of the report.

Method of Research

The Biotechnology market research provides hands-on data, after an acute analysis conducted by the experts, who have used the Porters Five Force Models parameters. Experts valuable inputs are outlined in the report, outlining the current norms along with the names of the leading industry participants and the chain network around the world. An extensive review of the parent industry, combined with the growth prospects, governing factors and macro-economic aspects are also covered in the report, in terms of segmentation. The market research has been done using two methods, namely primary and secondary. These methods help achieve a better understanding of the worldwide Biotechnology market, keeping in mind the threats, opportunities, strengths and weaknesses in the industry.

Market Key Player

Johnson & Johnson Services, Inc.F. Hoffmann-La Roche LtdPfizerMerck &SanofiAstraZenecaGileadCELGENE CORPORATIONBiogenAmgen, IncAbbottNovo Nordisk A/SNovartis AGLonza

Table of Content

1 Report Overview

2 Global Growth Trends by Regions

3 Competition Landscape by Key Players

4 Breakdown Data by Type (2015-2026)

5 Biotechnology Breakdown Data by Application (2015-2026)

6 North America

7 Europe

8 China

9 Japan

10 Southeast Asia

11 India

12 Central & South America

13 Key Players Profiles

14 Analysts Viewpoints/Conclusions

15 Appendix

Continuous

For further information on this report, visit https://www.wiseguyreports.com/reports/5506311-covid-19-impact-on-global-biotechnology-market-size-status-and-forecast-2020-2026

NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

[emailprotected]

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Read more:
Global Biotechnology Market 2020 COVID-19 Impact, Share, Trend, Segmentation and Forecast to 2026 - 3rd Watch News

Read More...

Outlook into the Protective Clothing for Life Sciences Industry Global Market to 2028 – Growth in Biotechnology and Healthcare Spending Presents…

Friday, July 3rd, 2020

DUBLIN, June 29, 2020 /PRNewswire/ -- The "Global Protective Clothing Market for Life Sciences Industry 2019-2028" report has been added to ResearchAndMarkets.com's offering.

The publisher predicts that the global market for protective clothing for life sciences industry would witness a CAGR of 6.26% over the forecast period 2019-2028.

The growth of this market is primarily being driven by the growing demand for protective clothing from end-users. Additionally, the large investments in research & development and the stringent rules & regulations to ensure the safety of workers at workplaces also helping in bringing growth to the market. Furthermore, the enhanced biotechnology & healthcare expenditure, along with the rising demand from developing nations for PPE, open up several new opportunities for market growth.

However, the high cost of these clothing as well as the surge in the outsourcing & automation of pharma manufacturing, are hindering the market growth. Moreover, manufacturing complexities, evolving market trends, and the stiff competition from generic products are creating hurdles in the protective clothing market for life sciences industry's growth.

The global market spans across the regions of North America, Latin America, the Middle East and Africa, the Asia-pacific, and Europe.

The Asia-Pacific is poised to be the fastest-growing market globally during the forecasted period. The improvement in the medical hygiene standard in the region is attributable to the growth of the market in the APAC. China is the largest market in this region, holding the maximum market share. It is also one of the most lucrative markets in the world for various industries, ranging from medical products to pharmaceuticals. The country's healthcare industry is growing speedily, thanks to the rapid urbanization, increasing disease burden, favorable demographic trends, growth in income, and the economy's overall growth. This has significantly boosted the nation's protective clothing market for life sciences industry.

Major players engaged in the protective clothing market for life sciences industry are Kimberly-Clark, WL Gore & Associates Inc, Honeywell International Inc, DuPont, Kappler, Uvex Group, Tronex International Inc, Irudek Group, BioClean (By Ansell), Lakeland Inc, VF Corporation, Ansell Ltd, Berkshire Corporation, 3M Company, and Lindstrom Group.

The 3M Company, is a US-based multinational conglomerate, with operations in over 65 countries. It functions across several domains, catering to end-users across a range of industries. In the protective clothing segment, it offers head & face protection, protective suits & apparel, protective eyewear, etc. the company's strong R&D infrastructure helps it in developing innovative products, making 3M a frontrunner in most of its businesses. In May 2020, the US Department of Defense awarded 3M two contracts to manufacture N95 respirators in the country's efforts to contain the coronavirus outbreak.

Key Topics Covered:

1. Global Protective Clothing Market for Life Sciences Industry - Summary

2. Industry Outlook2.1. Market Definition2.2. Key Insights2.2.1. Disposable Clothing Type to Dominate the Market2.2.2. Asia-Pacific to Witness the Highest Growth2.2.3. Cleanroom Clothing Holds Largest Market Share Amongst Applications2.3. Porter's Five Force Analysis2.3.1. Threat of New Entrants2.3.2. Threat of Substitute2.3.3. Bargaining Power of Suppliers2.3.4. Bargaining Power of Buyers2.3.5. Threat of Competitive Rivalry2.4. Market Attractiveness Index2.5. Vendor Scorecard2.6. Value Chain Analysis2.7. Market Drivers2.7.1. Growing Demand from End-User2.7.2. Huge Investments in R&D2.7.3. Stringent Rules and Regulations2.8. Market Restraints2.8.1. High Cost of Protective Cloths2.8.2. Surge in Outsourcing and Automation of Pharmaceutical Manufacturing2.9. Market Opportunities2.9.1. Growth in Biotechnology and Healthcare Spending2.9.2. Increasing Demand from Emerging Economies2.10. Market Challenges2.10.1. Complexity in Manufacturing2.10.2. Growing Price Competition in Generic Products and Evolving Market Trends

3. Global Protective Clothing Market for Life Sciences Industry Outlook - by Type3.1. Disposable3.2. Reusable

4. Global Protective Clothing Market for Life Sciences Industry Outlook - by Product4.1. Suits/Coveralls4.2. Gloves4.3. Aprons4.4. Facemasks and Hats4.5. Protective Eyewear and Cleanroom Goggles4.6. Footwear and Overshoes4.7. Wipes4.8. Others

5. Global Protective Clothing Market for Life Sciences Industry Outlook - by Application5.1. Cleanroom Clothing5.1.1. Pharmaceutical5.1.2. Biotechnology5.1.3. Medical5.2. Radiation Protection5.3. Bacterial/Viral Protection5.4. Chemical Protection5.5. Others

6. Global Protective Clothing Market for Life Sciences Industry - Regional Outlook6.1. North America6.1.1. Market by Type6.1.2. Market by Product6.1.3. Market by Application6.1.3.1. Market by Cleanroom Clothing6.1.4. Country Analysis6.1.4.1. United States6.1.4.2. Canada6.2. Europe6.2.1. Market by Type6.2.2. Market by Product6.2.3. Market by Application6.2.3.1. Market by Cleanroom Clothing6.2.4. Country Analysis6.2.4.1. United Kingdom6.2.4.2. Germany6.2.4.3. France6.2.4.4. Spain6.2.4.5. Italy6.2.4.6. Russia6.2.4.7. Rest of Europe6.3. Asia-Pacific6.3.1. Market by Type6.3.2. Market by Product6.3.3. Market by Application6.3.3.1. Market by Cleanroom Clothing6.3.4. Country Analysis6.3.4.1. China6.3.4.2. Japan6.3.4.3. India6.3.4.4. South Korea6.3.4.5. Asean Countries6.3.4.6. Australia & New Zealand6.3.4.7. Rest of Asia-Pacific6.4. Latin America6.4.1. Market by Type6.4.2. Market by Product6.4.3. Market by Application6.4.3.1. Market by Cleanroom Clothing6.4.4. Country Analysis6.4.4.1. Brazil6.4.4.2. Mexico6.4.4.3. Rest of Latin America6.5. Middle East and Africa6.5.1. Market by Type6.5.2. Market by Product6.5.3. Market by Application6.5.3.1. Market by Cleanroom Clothing6.5.4. Country Analysis6.5.4.1. United Arab Emirates6.5.4.2. Turkey6.5.4.3. Saudi Arabia6.5.4.4. South Africa6.5.4.5. Rest of Middle East & Africa

7. Competitive Landscape7.1. Dupont7.2. Kimberly-Clark7.3. Ansell Ltd7.4. 3M Company7.5. Lakeland Inc7.6. Bioclean (By Ansell)7.7. Honeywell International Inc7.8. Irudek Group7.9. Berkshire Corporation7.10. Kappler7.11. Tronex International Inc.7.12. Uvex Group7.13. Lindstrom Group7.14. WL Gore & Associates Inc7.15. VF Corporation

8. Methodology & Scope8.1. Research Scope8.2. Sources of Data8.3. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/dnoyv8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

View post:
Outlook into the Protective Clothing for Life Sciences Industry Global Market to 2028 - Growth in Biotechnology and Healthcare Spending Presents...

Read More...

Join Our Upcoming Webinar on the Topic of Crop Biotechnology – IDTechEx.com

Friday, July 3rd, 2020

Webinar Title: Crop Biotechnology: Could Genome Editing Revolutionise Agriculture?

Date: Tuesday 7 July 2020

In this webinar, Technology Analyst Dr Michael Dent will present an overview of IDTechEx's recent research into the crop biotechnology industry, focusing on the potential of genome editing to revolutionise the field.

The webinar will compare genome editing technologies, such as CRISPR, TALENs and ZFNs, with more established genetic modification techniques, providing technical, consumer and market insights. It will also discuss the challenges faced by genetic modification techniques and how genome editing technologies could overcome them.

The webinar will include:

Date: Tuesday 7 July 2020

Duration: 30 minutes

Webinar #1: Asia-Pacific

9:00am (GMT+8) Singapore, Taipei, Beijing

9:00am (GMT+8) Australian Western Standard Time

10:00am (GMT+9) Tokyo, Seoul

10:30am (GMT+9.30) Australian Central Time

11:00am (GMT+10) Australian Eastern Time

1:00pm (GMT+12) Auckland, New Zealand

Webinar #2: Europe

10:00am (GMT) London

11:00am (GMT+1) Amsterdam, Berlin, Rome

12:00noon (GMT+2) Athens, Jerusalem

Webinar #3: Americas

9:00am (Pacific Time PT) USA & Canada

10:00am (Mountain MST) USA & Canada

11:00am (Central CST) USA & Canada

12:00noon (Eastern EST) USA & Canada

5:00pm (GMT) London

Go here to read the rest:
Join Our Upcoming Webinar on the Topic of Crop Biotechnology - IDTechEx.com

Read More...

Investing in the vaccines of tomorrow: the case for biotechnology – Livewire Markets

Saturday, June 27th, 2020

Technology may typically be thought of in termsof computers and communications but its use inthe sphere of biotechnology is saving lives andchanging how we treat diseases. While investingin this area has obvious appeal from a social andmoral perspective, it can also be a highly lucrativespace as a growth investment in a portfolio.

Biotechnology is a sub-industry of the healthcaresector, which is typically divided into two spheres:

Biotechnology specifically refers to technologiesthat use biological processes, capturing companies that focus on research, development, manufacturing and/or marketing of products based onbiological and genetic information. The differenttypes of biotechnology include biological drugs,vaccines, immunotherapy, gene therapy, orphandrugs and genetic engineering.

While it may sound like a newer industry, biotechnology has a long rich history the creation ofpenicillin is in fact a form of biotechnology. Thecontinued improvements in technology over timehave also benefitted the biotechnology industry,enhancing the ability to access and use biologicalprocesses which we may not have even beenaware existed in the past. For example, DNAsequencing has revolutionised our ability to diagnose certain health concerns in individuals.Genome editing is a newer technology which maytransform how we treat or cure genetic diseases.

Demand is only likely to continue, not just on thebasis of the permanent need for treatments andvaccines for existing and yet to be identifieddiseases, but also because of the ability toimprove the way in which we treat. Imagine aworld where any illness you have can be treatedwith a drug specifically designed to work withyour genes and therefore minimise negativeside-effects and reduce recovery time? This is afuture that biotechnology is working towards.

It is no secret that biotechnology has experiencedextraordinary growth in recent times. Even in Australia, the fact that CSL Limited toppled Commonwealth Bank and BHP this year to become thelargest company by market capitalisation is anindication of the growing importance and value ofbiotechnology (1).

Biotechnology is predicted to be valued at morethan US$729bn by 2025, compared to US$295bntoday (2), and will continue to grow, driven by thegrowing global population and the need for affordable, effective treatments and vaccines to supporttreatment in the population.

Biotechnology will also be a beneficiary of population ageing, particularly in Western countries. Thereason for this is that an increase in the volume ofolder citizens is likely to have an accompanyingand proportional increase in the volume of age-related diseases such as cardiovascular disease,dementia or arthritis, all needing treatment (3).

Gilead is one example of a company with prospects in this space. Gilead is already well-knownfor its highly effective HIV treatments but is alsotargeting US and European approvals to market a drug called Filgotinib to treat rheumatoidarthritis (4).

In a demonstration of the growth in this industry,this year alone, 30-35 biotechnology companiesare anticipated to go public, raising approximatelyUS$3.5bn (5)

The COVID-19 pandemic may assist in accelerating the growth in biotechnology. Biotechnologycompanies have been at the forefront in seekingvaccines and cures for COVID-19. There arecurrently 11 potential COVID-19 vaccines in clinical evaluation (that is, undergoing testing) and afurther 128 in pre-clinical evaluation (6). Moderna isan example of a major biotechnology companyrunning clinical testing currently. It was the firstcompany to start human trials and anticipatesentering phase 3 trials with 30,000 participants byJuly (7).

The healthcare sector as a whole is likely to seegreater investment as a result of the COVID-19pandemic. For example, national health spendinggrowth in the US is expected to average 5.4%annually through 2028, reaching US$6tr a year (8).Biotechnology will also be a beneficiary of thisincreased investment.

Australian investors tend to have a concentrateddomestic exposure to biotechnology given thedominance of players such as CSL, Cochlear orResMed but may be missing the growth and diversification offered overseas. The US in particular ispositioned as the global centre of biotechnology.

The US biotechnology industry is valued at113.3bn (9), approximately 14x the size of the Australian biotechnology industry (10).

The reason for the US dominance in this field isdue in part to the world-renowned US Food & DrugAdministration (FDA) approval process and alsoto the size of its customer base.

Any companies seeking access to distribute theirproducts in the US market need to submit to FDAevaluation and in turn, many companies havesought to base themselves there for easieraccess to the process and for easier distributionand marketing to US consumers.

Australian investors can consider the US biotechnology industry as a diversification measure,along with exposure to a high growth segmentinternationally.

Biotechnology can be a high-risk industry, withhigh costs for drug development and high chances of failure. The rewards for successful trials canalso be immense.

To put this in perspective, in any given year, 54% ofclinical phase 3 trials typically fail for a range ofreasons (11), with average costs for developing adrug estimated at more than US2.1bn (12). The trialsand approval process can take years, often 10years or more, with less than 12% reachingapproved status with the FDA (13).

Biotech and healthcare companies then deriverevenue from approved products using patents,which last approximately 20 years from the dateof application (but also require maintenance feesand in some cases, can be extended) (14). Thismeans generic, cheaper versions from competitors cannot be sold in this period, allowing a company an effective monopoly over a particular formof treatment in that time. Of course, once thispatent expires, competitors can enter, so companies will continue research, development and testing on a permanent basis in the hope of findingthe next major treatment they can generaterevenue from.

Another source of return for this industry is from ahigh rate of merger and acquisition activity. Smaller and mid-size biotechnology companies areoften targets for larger firms, wanting to expandwith complementary capabilities they might notpreviously have had. Its a mutually beneficial relationship, providing smaller and mid-size companies with the capital they need to finance development and testing.

Mergers and acquisitions for biotechnology wasvalued at US$23bn in 2019 (15). Pre-COVID-19,activity was tipped to step up in activity for 2020,with oncology, cardiovascular/metabolic disease, immunology, infectious disease and centralnervous system disorders anticipated to benefit (16).

Investment and value from biotechnology isexpected to grow in coming years. While the trendalready existed due to continuous tech improvements and the needs of a growing population, theCOVID-19 pandemic has created a new spotlighton this area which may accelerate its growth.

While Australian investors are likely to already beexposed to this growth segment in the concentrated domestic market, they may be missingexposure to the US, which dominates the globalmarket for biotechnology.

There are a range of ways to access the biotechnology industry.Investors could consider direct shares in biotechnology companies or alternatively consider managed funds. Direct shares can be a high-riskapproach due to the high failure rates of drug testing and long periods of development (i.e., longperiods where there may be no or a limited returnon investment). Theres also the element ofchance has the investor picked the winner? Itcould take years to know.

Managed investments, be it an actively managedfund or passive options like ETFs, can assist inmanaging the risks by spreading it across a largernumber of companies. Investors could choose toinvest by taking a sector approach and investingin a fund focusing on broader healthcare, or lookat industry-specific options focusing on biotechnology. ETFS S&P Biotech ETF (ASX:CURE)is one such example that offers broad exposure toUS biotechnology.

ETFS S&P Biotech ETF (ASX:CURE),offers investors exposure to US biotechnology companies engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

For more information on investing in biotechnology please hit the 'CONTACT' button below.

Footnotes

Read this article:
Investing in the vaccines of tomorrow: the case for biotechnology - Livewire Markets

Read More...

Why Dynavax, Novavax, and Vir Biotechnology Stocks Jumped Today – The Motley Fool

Saturday, June 27th, 2020

What happened

The stocks of several biotechs focused on developing treatments and vaccines for COVID-19 jumped on Wednesday. Shares of Dynavax Technologies (NASDAQ:DVAX) were up 4% as of 3:13 p.m. EDT today after rising as much as 10.1% earlier in the day. Novavax (NASDAQ:NVAX) was up 13.4%, and shares of Vir Biotechnology (NASDAQ:VIR) were soaring 16.8% higher.

None of these companies reported news today. But the overall stock market fell on concerns about the increased number of COVID-19 cases in the U.S. This bad news translated to good news for Dynavax, Novavax, and Vir as investors scooped up shares of the key players in the fight against the coronavirus.

Image source: Getty Images.

Buying coronavirus-focused biotech stocks just because the pandemic appears to be worsening isn't a great idea without assessing the overall prospects for each individual stock. The dynamics are quite different for Dynavax, Novavax, and Vir.

Dynavax is the only one of the three to already have an approved product of any kind on the market. Its hepatitis B vaccine Heplisav-B generated $10.5 million in sales in the first quarter. The CpG 1018 adjuvant used in Heplisav-B is also being used in four COVID-19 vaccines, including ones developed by Chinese drugmakers Clover Biopharmaceuticals and Sinovac Biotech.

Novavax appears to be on track to win its first Food and Drug Administration approval, though. The company reported positive results in March from a late-stage study of flu vaccine NanoFlu. The vaccine could potentially generate peak sales in the ballpark of $1.7 billion if approved, according to one analyst's estimate. Novavax also has a promising COVID-19 vaccine in development that's in a phase 1/2 clinical trial.

Meanwhile, Vir Biotechnology has three clinical programs. The company thinks that its lead candidate, VIR-2218, which is being developed in collaboration with Alnylam Pharmaceuticals, holds the potential to be a functional cure for hepatitis B in combination with other therapies. Vir is also evaluating three COVID-19 therapies in pre-clinical testing.

Higher numbers of COVID-19 cases don't necessarily translate to greater prospects for any of these companies. But headlines about the pandemic definitely drive higher interest in their stocks.

The main thing to watch with each of these biotechs is their pipeline progress. For Dynavax, investors will also want to keep their eyes on sales of Heplisav-B in the coming quarters. Novavax expects to report initial results from its COVID-19 vaccine study in July. Vir plans to advance its VIR-7831 and VIR-7832 antibody therapies for COVID-19 directly into phase 2 testing this summer pending FDA review.

Go here to see the original:
Why Dynavax, Novavax, and Vir Biotechnology Stocks Jumped Today - The Motley Fool

Read More...

GAT-B 2020 and BET 2020 postponed, new dates to be announced soon – Careers360

Saturday, June 27th, 2020

NEW DELHI: Keeping in view the Covid-19 situation, Regional Centre for Biotechnology (RCB), Faridabad has postponed the Graduate Aptitude Test 2020 which was scheduled for June 30.

The Department of Biotechnology, Ministry of Science and Technology has also postponed the Biotechnology Eligibility Test 2020 which was also scheduled on June 30.

The new dates of the GAT-B 2020 and BET-2020 exam will be announced soon. The admit card of GAT-B 2020 was released on June 25. However, the admit card link has been removed now. The admit card of GAT-B 2020 will be released again.

The All India level entrance examination of GAT-B 2020 is conducted for admission to DBT- supported postgraduate programmes in all the participating institutions.

Biotechnology Eligibility Test is conducted to award the DBT-Junior Research Fellowship for pursuing research in biotechnology and life sciences.

Write to us at news@careers360.com

Stay updated with latest Education News

More From Team Careers360

Visit link:
GAT-B 2020 and BET 2020 postponed, new dates to be announced soon - Careers360

Read More...

Page 25«..1020..24252627..3040..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick